Atea Pharmaceuticals, Inc. Quarterly Accrued Income Taxes, Noncurrent in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.
Summary
Atea Pharmaceuticals, Inc. quarterly Accrued Income Taxes, Noncurrent history and growth rate from Q4 2021 to Q3 2024.
  • Atea Pharmaceuticals, Inc. Accrued Income Taxes, Noncurrent for the quarter ending September 30, 2024 was $6.2M, a 10.4% increase year-over-year.
Accrued Income Taxes, Noncurrent, Quarterly (USD)
Accrued Income Taxes, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.2M +$584K +10.4% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.05M +$556K +10.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.9M +$529K +9.85% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.76M +$503K +9.57% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $5.62M +$447K +8.65% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $5.49M -$514K -8.56% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.37M -$559K -9.42% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $5.26M -$677K -11.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $5.17M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $6.01M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $5.93M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $5.93M Dec 31, 2021 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.